Back to Search
Start Over
[Aryl-hydrocarbon receptor as a potential target for anticancer therapy].
- Source :
-
Biomeditsinskaia khimiia [Biomed Khim] 2018 Sep; Vol. 64 (5), pp. 397-415. - Publication Year :
- 2018
-
Abstract
- Aryl-hydrocarbon receptor (Aryl Hydrocarbon Receptor, AHR) is a ligand-dependent transcription factor, whose functions are related to xenobiotic detoxification, response to inflammation, and maintenance of tissue homeostasis. Recent investigations suggest that AHR also plays an important role in the processes of carcinogenesis. Increased expression of AHR is observed in several types of tumors and tumor cell lines. In addition, it turned out that the composition of pharmaceutical drugs used in oncotherapy includes some ligands AHR. These facts allow us to consider an aryl-hydrocarbon receptor as a potential target for anticancer therapy, especially for the treatment of severe cancers whose treatment options are very limited or do not exist at all. In this review the examples of AHR ligands' effect on tumor cell cultures and on model mice lines with AHR-dependent response are discussed.
Details
- Language :
- Russian
- ISSN :
- 2310-6972
- Volume :
- 64
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Biomeditsinskaia khimiia
- Publication Type :
- Academic Journal
- Accession number :
- 30378556
- Full Text :
- https://doi.org/10.18097/PBMC20186405397